Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 2008 May;50(5):346-52.
doi: 10.1111/j.1469-8749.2008.02053.x. Epub 2008 Mar 19.

A milk-free diet downregulates folate receptor autoimmunity in cerebral folate deficiency syndrome

Affiliations
Clinical Trial

A milk-free diet downregulates folate receptor autoimmunity in cerebral folate deficiency syndrome

Vincent T Ramaekers et al. Dev Med Child Neurol. 2008 May.

Abstract

In cerebral folate deficiency syndrome, the presence of autoantibodies against the folate receptor (FR) explains decreased folate transport to the central nervous system and the clinical response to folinic acid. Autoantibody crossreactivity with milk FR from different species prompted us to test the effect of a milk-free diet. Intervention with a milkfree diet in 12 children (nine males, three females; mean age 6y [SD 4y 11mo], range 1-19y), decreased autoantibody titer significantly from 2.08pmol of FR blocked per ml of serum (SD 2.1; range 0.24-8.35) to 0.35pmol (SD 0.49; range 0-1.32; p=0.012) over 3 to 13 months, whereas FR autoantibody titer increased significantly to 6.53 (SD 6.08; range 0.54-14.07; p=0.013) in nine children who were reexposed to milk for 6 to 14 weeks. In 12 children on a normal diet (eight males, four females; mean age 5y 5mo [SD 4y 1mo], range 1y 6mo-16y 4mo), the antibody titer increased significantly from 0.84pmol of FR blocked per ml (SD 0.39; range 0.24-1.44) to 3.04pmol (SD 1.42; range 0.84-6.01; p=0.001) over 10 to 24 months. Decreasing the autoantibody titer with a milk-free diet in conjunction with folinic acid therapy may be advocated for these patients.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Correlation between blocking folate receptor (FR) autoantibody titer and cerebrospinal fluid (CSF) folate level in patients with cerebral folate deficiency (CFD). Filled circles represent non-CFD patients with normal levels of folate in CSF who tested negative for the autoantibody
Figure 2
Figure 2
(a) Effect of dietary intervention with a milk-free diet followed by re-exposure to milk on the antibody titer of nine patients with cerebral folate deficiency (CFD) with autoantibodies against the folate receptor (FR) protein. The remaining three children who continued on a milk-free diet and whose autoantibody titer remained low are not shown. Each individual is depicted by a symbol and identified by the patient number from Table I. (b) Blocking autoantibody titer in 12 CFD patients on a normal diet containing milk and milk-derived products. Each patient is depicted by a symbol and identified by the patient number from Table II. Inset shows the mean, SEM, and statistical significance (determined by the paired t-test) of the autoantibody titer for all participants in each group.
Figure 3
Figure 3
Cross-reactivity of folate receptor autoantibodies against folate receptor from different species (n=9; mean and SEM). The p values were determined by paired t-test.

References

    1. Ramaekers VT, Hausler M, Opladen T, Heimann G, Blau N. Psychomotor retardation, spastic paraplegia, cerebellar ataxia and dyskinesia associated with low 5-methyltetrahydrofolate in cerebrospinal fluid: a novel neurometabolic condition responding to folinic acid substitution. Neuropediatrics. 2002;33:301–308. - PubMed
    1. Ramaekers VT, Blau N. Cerebral folate deficiency. Dev Med Child Neurol. 2004;46:843–851. - PubMed
    1. Holm J, Hansen SI, Hoier-Madsen M, Bostad L. High-affinity folate binding in human choroid plexus. Characterization of radioligand binding, immunoreactivity, molecular heterogeneity and hydrophobic domain of the binding protein. Biochem J. 1991;280:267–271. - PMC - PubMed
    1. Spector R, Johanson C. Micronutrient and urate transport in choroid plexus and kidney: implications for drug therapy. Pharm Res. 2006;23:2515–2524. - PubMed
    1. Rothenberg SP, da Costa MP, Sequeira JM, et al. Autoantibodies against folate receptors in women with a pregnancy complicated by a neural-tube defect. N Engl J Med. 2004;350:134–142. - PubMed

Publication types

MeSH terms